Opportunity
CanadaBuys #20164479
Sole-Source Procurement of Stryker Neuro-Intervention Devices for Santé Québec CHU de Québec-Université Laval
Posted
August 13, 2026
Respond By
August 24, 2026
Identifier
20164479
NAICS
423450, 423490
Santé Québec CHU de Québec-Université Laval, a government healthcare institution, is seeking to procure a comprehensive suite of neuro-intervention supplies through a sole-source contract with Stryker Canada ULC. - Government Buyer: - Santé Québec CHU de Québec-Université Laval (Government of Canada) - OEMs and Vendors: - Stryker Canada ULC (sole OEM and vendor) - Products/Services Requested: - Embolization coils for aneurysms and non-aneurysm use - Neuro-interventional microguides - Microcatheters for embolization (compatible with DMSO embolic agents, coils, stents, and flow diverters) - Distal access catheters (with and without balloons) - Non-detachable mechanical thrombectomy systems - Embolization systems for flow diverters - Single-lumen and double-lumen angioplasty/occlusion balloons - Support tuteurs for aneurysm embolization - Unique or Notable Requirements: - All products must be Santé Canada homologated and supplied under a valid establishment license - Vendor must provide a Québec-based clinical support representative and 24/7 clinical assistance - Ability to support urgent orders and ensure rapid delivery - Price consistency for trial products - Option to add new, clinically impactful products during the contract period - Contract Duration: - 36 months (3 years)
Description
Santé Québec CHU de Québec-Université Laval intends to enter into a sole-source contract exceeding the public tender threshold with Stryker Canada ULC for neuro-intervention supplies. The contract duration is 36 months and is expected to conclude on August 28, 2026. The procurement includes multiple lots of specialized neuro-interventional devices such as embolization coils, microcatheters, and thrombectomy systems. The supplier must meet specific criteria including Santé Canada homologation, a valid establishment license, and provide clinical support with timely delivery. Interested companies must submit electronically by August 23, 2026, demonstrating capacity to fulfill the contract.